Convatec Group PLC (LON:CTEC)
223.40
-8.60 (-3.71%)
At close: Feb 3, 2026
Convatec Group Revenue
Convatec Group had revenue of $1.18B USD in the half year ending June 30, 2025, with 11.79% growth. This brings the company's revenue in the last twelve months to $2.36B, up 7.06% year-over-year. In the year 2024, Convatec Group had annual revenue of $2.29B with 6.85% growth.
Revenue (ttm)
$2.36B
Revenue Growth
+7.06%
P/S Ratio
2.63
Revenue / Employee
$235.57K
Employees
10,000
Market Cap
4.52B GBP
Revenue Chart
* This company reports financials in USD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 2.29B | 146.80M | 6.85% |
| Dec 31, 2023 | 2.14B | 69.90M | 3.37% |
| Dec 31, 2022 | 2.07B | 34.20M | 1.68% |
| Dec 31, 2021 | 2.04B | 144.00M | 7.60% |
| Dec 31, 2020 | 1.89B | 67.10M | 3.67% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| AstraZeneca | 43.24B |
| GSK plc | 32.17B |
| Haleon | 11.02B |
| Smith & Nephew | 4.33B |
| Hikma Pharmaceuticals | 2.35B |
| Spire Healthcare Group | 1.55B |
| CVS Group | 673.20M |
| Genus | 672.80M |
Convatec Group News
- 1 day ago - Indian Army Receives 3rd Batch of Made-in-India Johnnette JM-1 Loitering Munitions Showcased at 77th Republic Day Parade at Kartavya Path - Business Upturn
- 5 days ago - ART100 Becomes Inspira's First System to Complete Clinical Evaluation and Enters Budgeted Procurement at Top U.S. Medical Center - Benzinga
- 5 days ago - Rogers Comm Posts Higher Q4 Earnings; Raises FY26 Guidance; Declares Dividend - Nasdaq
- 12 days ago - AMERICAN REALTY INVESTORS INC Of Transcontinental Realty Shows Optimism, Buys $3.89M In Stock - Benzinga
- 13 days ago - Inspira Advances to Final Governmental Budgetary Validation Procedures for Previously Announced Binding Purchase Orders - Benzinga
- 19 days ago - 10% Owner Of Transcontinental Realty Purchased $3.89M In Stock - Benzinga
- 20 days ago - MBAK Energy Solutions, Inc. (OTC:MBAK) Nominates Dr. Konda Shiva to the Board of Directors - Benzinga
- 4 weeks ago - The End of Shots? 5 Biotech Stocks Rethinking Diabetes - Benzinga